HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Pere Domingo Selected Research

lopinavir (Kaletra)

7/2015Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial.
7/2013Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
1/2012Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudine.
11/2011Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study.
1/2008Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.
1/2007Lopinavir/ritonavir pharmacokinetics in HIV and hepatitis C virus co-infected patients without liver function impairment: influence of liver fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Pere Domingo Research Topics

Disease

33Infection
06/2015 - 09/2003
32Lipodystrophy
01/2015 - 12/2002
13Inflammation
06/2015 - 03/2008
13HIV Infections (HIV Infection)
03/2015 - 07/2005
11Insulin Resistance
03/2015 - 10/2003
9Acquired Immunodeficiency Syndrome (AIDS)
06/2013 - 04/2003
5Exanthema (Rash)
01/2014 - 10/2004
4Obesity
01/2015 - 09/2009
4Liver Cirrhosis (Hepatic Cirrhosis)
04/2014 - 01/2007
4Necrosis
01/2012 - 01/2006
4Tuberculosis (Tuberculoses)
01/2011 - 11/2005
3Fibrosis (Cirrhosis)
06/2015 - 01/2007
3Disease Progression
06/2015 - 04/2007
3Kidney Diseases (Kidney Disease)
11/2014 - 01/2014
3Hypercholesterolemia
07/2013 - 04/2004
3Hypertrophy
01/2013 - 08/2007
3Dyslipidemias (Dyslipidemia)
05/2012 - 07/2004
3Viremia
04/2010 - 09/2005
3Progressive Multifocal Leukoencephalopathy
07/2009 - 04/2003
3Lipomatosis
11/2006 - 04/2004
2Hepatitis B
07/2015 - 07/2009
2Osteoporosis
07/2015 - 12/2014
2Metabolic Bone Diseases (Osteopenia)
07/2015 - 12/2014
2Drug Toxicity (Drug Safety)
04/2014 - 05/2012
2Hepatitis C
04/2014 - 02/2012
2Hypertension (High Blood Pressure)
07/2013 - 01/2010
2Peripheral Nervous System Diseases (PNS Diseases)
06/2013 - 01/2013
2Pancreatitis
06/2013 - 01/2013
2Fever (Fevers)
01/2013 - 12/2008
2Hypersensitivity (Allergy)
01/2010 - 06/2002
2Pneumonia (Pneumonitis)
08/2009 - 09/2008
2Bacterial Meningitis
08/2009 - 12/2004
2Hypertriglyceridemia
07/2004 - 04/2004
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2014

Drug/Important Bio-Agent (IBA)

9Carbon MonoxideIBA
06/2015 - 12/2004
8RNA (Ribonucleic Acid)IBA
07/2015 - 09/2003
7abacavir (Ziagen)FDA Link
07/2015 - 06/2002
7Ritonavir (Norvir)FDA Link
07/2015 - 11/2005
7Lamivudine (3TC)FDA Link
07/2015 - 11/2005
7Protease Inhibitors (Protease Inhibitor)IBA
03/2015 - 09/2003
7Stavudine (Zerit)FDA LinkGeneric
01/2014 - 07/2004
7efavirenz (Sustiva)FDA Link
02/2012 - 09/2003
6tenofovirFDA Link
07/2015 - 07/2004
6lopinavir (Kaletra)FDA Link
07/2015 - 01/2007
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 01/2007
6AdipokinesIBA
03/2013 - 01/2006
6CytokinesIBA
03/2013 - 12/2004
6Messenger RNA (mRNA)IBA
10/2012 - 11/2006
5MK 0518FDA Link
01/2014 - 11/2009
5Triglycerides (Triacylglycerol)IBA
05/2012 - 10/2003
4Mitochondrial DNA (mtDNA)IBA
08/2014 - 09/2006
4Proteins (Proteins, Gene)IBA
08/2014 - 01/2009
4Insulin (Novolin)FDA Link
12/2012 - 01/2007
4Reverse Transcriptase InhibitorsIBA
08/2011 - 03/2002
3Interleukin-6 (Interleukin 6)IBA
10/2013 - 04/2008
3Interleukin-18 (Interleukin 18)IBA
10/2013 - 05/2012
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2013 - 01/2010
3triphosphoric acid (triphosphate)IBA
01/2013 - 04/2010
3HDL CholesterolIBA
12/2012 - 01/2007
3PPAR gammaIBA
10/2012 - 11/2006
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2012 - 07/2004
3AdiponectinIBA
05/2012 - 01/2006
3Zidovudine (Retrovir)FDA LinkGeneric
01/2012 - 10/2008
3Nevirapine (Viramune)FDA Link
08/2011 - 09/2003
3Didanosine (Videx)FDA LinkGeneric
01/2009 - 11/2005
3Rifampin (Rifampicin)FDA LinkGeneric
04/2007 - 10/2004
2atazanavir (Reyataz)FDA Link
03/2015 - 01/2012
2LDL CholesterolIBA
01/2015 - 11/2010
2Ribavirin (Virazole)FDA LinkGeneric
04/2014 - 06/2012
2Thymidylate SynthaseIBA
01/2013 - 04/2011
2fibroblast growth factor 21IBA
12/2012 - 11/2010
2Biological Markers (Surrogate Marker)IBA
11/2012 - 11/2010
2LeptinIBA
05/2012 - 01/2006
2Glucose (Dextrose)FDA LinkGeneric
01/2012 - 11/2010
2etravirine (TMC-125)FDA Link
07/2011 - 02/2011
2maravirocFDA Link
02/2011 - 01/2011
2Fatty Acids (Saturated Fatty Acids)IBA
10/2010 - 09/2006
2lamivudine drug combination abacavirFDA Link
09/2010 - 04/2006
2ThymidineIBA
04/2010 - 07/2009
2enfuvirtide (Fuzeon)FDA Link
11/2009 - 02/2007
2Saquinavir (Invirase)FDA Link
04/2007 - 11/2005
2Isoniazid (Ftivazide)FDA LinkGeneric
04/2007 - 11/2005
1Surface Antigens (Surface Antigen)IBA
07/2015
1emtricitabine (Emtriva)FDA Link
07/2015
1Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2015
1Antiviral Agents (Antivirals)IBA
06/2015
1fibrin fragment D (D-dimer)IBA
06/2015
1Integrase InhibitorsIBA
03/2015
1C-Reactive ProteinIBA
01/2015
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2015
1Monounsaturated Fatty AcidsIBA
01/2015
1telaprevirIBA
04/2014
1IntegrasesIBA
04/2014
1InterferonsIBA
04/2014
1lipopolysaccharide-binding proteinIBA
11/2013
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2013

Therapy/Procedure

29Highly Active Antiretroviral Therapy (HAART)
01/2015 - 12/2002
2Art Therapy
08/2014 - 05/2012
2Transplantation (Transplant Recipients)
01/2013 - 11/2007
1Therapeutics
01/2014